SCHEMBL10346903

SCHEMBL10346903

CCCCCCCCCCCCCC(=O)OCCN

nearest known ligand 0.77

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DGKA P23743 1/20 0.77
▸ MAPT P10636 2/20 0.66
▸ ALDH1A1 P00352 2/20 0.66
▸ THRB P10828 1/20 0.66
▸ CNR1 P21554 1/20 0.66
▸ DNM1 Q05193 1/20 0.62
▸ HTR2C P28335 1/20 0.61
▸ PRSS1 P07477 1/20 0.58
▸ PRSS2 P07478 1/20 0.58
▸ PRSS3 P35030 1/20 0.58
▸ PAM P19021 2/20 0.58
▸ TSHR P16473 1/20 0.55
▸ NAAA Q02083 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ LMNA P02545 3/20 0.53
▸ KDM4E B2RXH2 1/20 0.51
▸ DUSP3 P51452 1/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL976601 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL19376381 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL19402727 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL973787 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL3338674 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL5933172 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL974095 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL2678233 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL19397840 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL3344674 0.98 DGKA (0.74) DGKAMAPTALDH1A1THRBCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4388070-A1 WATER-SOLUBLE FILMS AND METHODS OF USE Nohbo, Inc. (US) 2024-06-26 — — EP claimed
CN-118139961-A Water-soluble films and methods of use 诺赫博股份有限公司 2024-06-04 — — CN claimed
WO-2023023493-A1 WATER-SOLUBLE FILMS AND METHODS OF USE NOHBO, INC. (US) 2023-02-23 — — WO claimed
CN-109563439-A Cleaning composition 因诺斯佩克活性化学物有限责任公司 2019-04-02 — — CN claimed
US-20240270912-A1 Water-Soluble Films and Methods of Use CMC Group, Inc. 2024-08-15 — — US disclosed
EP-4388070-A1 WATER-SOLUBLE FILMS AND METHODS OF USE Nohbo, Inc. (US) 2024-06-26 — — EP disclosed
CN-118139961-A Water-soluble films and methods of use 诺赫博股份有限公司 2024-06-04 — — CN disclosed
US-11970651-B2 Surface treatment agent DAIKIN INDUSTRIES, LTD. (JP) 2024-04-30 — — US disclosed
US-11932712-B2 Method of treating substrate DAIKIN INDUSTRIES, LTD. (JP) 2024-03-19 — — US disclosed
US-20240060233-A1 POLYMER DEPOSITION AND ATTACHMENT PROCESS FOR TEXTILES DAIKIN AMERICA, INC. (US) 2024-02-22 — — US disclosed
EP-4277502-A1 POLYMER DEPOSITION AND ATTACHMENT PROCESS FOR TEXTILES DAIKIN AMERICA, INC. (US) 2023-11-22 — — EP disclosed
CN-116568413-A Polymer deposition and attachment method for textile 大金美国股份有限公司 2023-08-08 — — CN disclosed
CN-109563439-A Cleaning composition 因诺斯佩克活性化学物有限责任公司 2019-04-02 — — CN disclosed
US-20170273995-A1 ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF CANTUARIA, GUILHERME H.C. 2017-09-28 — — US disclosed
US-20170273995-A1 ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF CANTUARIA, GUILHERME H.C. 2017-09-28 — — US disclosed
US-20170273995-A1 ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF CANTUARIA, GUILHERME H.C. 2017-09-28 — — US disclosed
WO-2012170952-A9 COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING SIRNA ACTIVITY NITTO DENKO CORPORATION (JP) 2013-02-21 — — WO disclosed
WO-2012170952-A2 COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING SIRNA ACTIVITY NITTO DENKO CORPORATION (JP) 2012-12-13 — — WO disclosed
EP-0183050-B1 LUBRICATING ADDITIVE PHILLIPS PETROLEUM COMPANY (US) 1990-05-09 — — EP disclosed
US-4250046-A POLYOXYALKYLENE GLYCOL PENNWALT CORPORATION (US) 1981-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170273995-A1 ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF PHOSPHO1, SGMS2, CHKB DGKA 171/4885MAPT 4121/4885ALDH1A1 657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback